Alk-Abelló A/S
🇩🇰Denmark
Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)
Completed
- Conditions
- First Posted Date
- 2012-03-09
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 8790
- Registration Number
- NCT01549340
A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)
Completed
- Conditions
- First Posted Date
- 2012-02-17
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 2765
- Registration Number
- NCT01535118
A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
- First Posted Date
- 2011-11-10
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 914
- Registration Number
- NCT01469182
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 199
- Registration Number
- NCT01454531
- Locations
- 🇪🇸
Hospital de Basurto, Bilbao, Spain
🇪🇸Hospital Universitario Infanta Cristina, Badajoz, Spain
🇪🇸Hospital Nuestra Señora de Sonsoles, Avila, Spain
A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 992
- Registration Number
- NCT01454544
- Locations
- 🇫🇷
Department of Respiratory Diseases, Lapeyronie Hospital, Montpellier, France
Avanz Phleum Pratense Maintenance Dose
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-22
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 450
- Registration Number
- NCT01438827
- Locations
- 🇩🇪
UntersuchungsZentrum für Dermatologie, Allergologie und Asthma, Berlin, Germany
House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-14
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 834
- Registration Number
- NCT01433523
- Locations
- 🇩🇪
Universitätsklinikum Rostock, Abteilung für Pneumologie Zentrum für Innere Medizin, Ernst Heydemann Strasse 6, Rostock, Germany
Tolerability of Grazax in Patients With Hayfever in Real Life Settings
- First Posted Date
- 2011-09-14
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 628
- Registration Number
- NCT01433510
- Locations
- 🇫🇷
Centre Hospitalier Universitaire, Nantes, France
Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense
- First Posted Date
- 2011-08-30
- Last Posted Date
- 2015-06-26
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 236
- Registration Number
- NCT01425788
- Locations
- 🇵🇱
Poradnia Alergologii i Chorob Pluc Uniwersyteckiego Szpitala Klinicznego Nr1 im. N. Barlickiego w Lodzi, Lodz, Poland
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-06-30
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- ALK-Abelló A/S
- Target Recruit Count
- 1501
- Registration Number
- NCT01385371
© Copyright 2024. All Rights Reserved by MedPath